RespireRx Pharmaceuticals Competitors and Similar CompaniesClear all
RespireRx Pharmaceuticals's competitors and similar companies include Shenzhen Salubris Pharmaceutical, JBCPL, Insud Pharma and Sumitomo Pharma.
 RespireRx Pharmaceuticals RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders. |  Shenzhen Salubris Pharmaceutical Shenzhen Salubris Pharmaceutical (深圳信立泰药业股份有限公司) is a pharmaceutical company that develops and supplies drugs. |  Insud Pharma Insud Pharma is a company engaged in scientific research, development, manufacturing, sales, and marketing of a range of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and branded pharmaceuticals. |  Sumitomo Pharma Sumitomo Pharma (住友ファーマ株式会社) is a company that manufactures and sells pharmaceuticals, veterinary medicines, and food additives. | ||
Founding Date | Founding Date 1988 | Founding Date 1998 | Founding Date 1976 | Founding Date 1977 | Founding Date 1897 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Glen Rock, US HQ | Locations Shenzhen, CN HQ | Locations HQ | Locations Madrid, ES HQ | |
Employees | Employees 233% decrease | Employees 3,596 | Employees 5,311 | Employees 6,2311% increase | Employees 4,980 |
Valuation ($) | Valuation ($) 613.3 k | Valuation ($) 5 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.2b (FY, 2025) | Revenue (est.) ₹41.5b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) ¥453.3b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods ¥1.1b (FY, 2025) | Cost of goods ₹13b (FY, 2026) | Cost of goods N/A | Cost of goods ¥175.6b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit ¥3.2b (FY, 2025) | Gross profit ₹29.1b (FY, 2026) | Gross profit N/A | Gross profit ¥333.5b (FY, 2026) |
Net income | Net income ($2.1m) (FY, 2022) | Net income ¥652.8m (FY, 2025) | Net income ₹7.1b (FY, 2026) | Net income N/A | Net income ¥106.9b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Shenzhen Salubris Pharmaceutical
HQ
Shenzhen, CN
Employees
3,596
Shenzhen Salubris Pharmaceutical (深圳信立泰药业股份有限公司) is a pharmaceutical company that develops and supplies drugs.
View company
JBCPL
HQ
Employees
5,311
JBCPL (JB Chemicals and Pharmaceuticals) is a pharmaceutical company.
View companyInsud Pharma
HQ
Madrid, ES
Employees
6,231↑ 1% increase
Insud Pharma is a company engaged in scientific research, development, manufacturing, sales, and marketing of a range of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and branded pharmaceuticals.
View companySumitomo Pharma
HQ
Osaka, JP
Employees
4,980
Sumitomo Pharma (住友ファーマ株式会社) is a company that manufactures and sells pharmaceuticals, veterinary medicines, and food additives.
View company